Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
<p>Abstract</p> <p>Background</p> <p>The transcription factor 7-like 2 (TCF7L2) is a critical component of the Wnt/β-catenin pathway. Aberrant <it>TCF7L2 </it>expression modifies Wnt signaling and mediates oncogenic effects through the upregulation of <it...
Main Authors: | Schmutzler Rita K, Meindl Alfons, Hemminki Kari, Shanmugam Kalai S, Burwinkel Barbara, Sutter Christian, Wappenschmidt Barbara, Kiechle Marion, Bartram Claus R, Frank Bernd |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/268 |
Similar Items
-
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
by: Bugert Peter, et al.
Published: (2007-05-01) -
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
by: Varon-Mateeva Raymonda, et al.
Published: (2009-12-01) -
The transcription factor 7-like 2 (<it>TCF7L2</it>) polymorphism may be associated with focal arteriolar narrowing in Caucasians with hypertension or without diabetes: the ARIC Study
by: Boerwinkle Eric, et al.
Published: (2010-05-01) -
Study of transcription factor 7-like 2 (TCF7L2) gene polymorphism in cirrhotic patients with diabetes
by: Mona Mahmoud Hassouna, et al.
Published: (2023-10-01) -
Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
by: Junyi Li, et al.
Published: (2021-09-01)